Cargando…

Conjugation of Cetuximab – Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines

Cancer is life-threatening disease and being global health problems. Chemotherapy is one of the most used therapy for cancer since many years ago. Chemotherapy is also toxic for normal cell, not specific to the target cells. Consequently, chemotherapy has various side effects. Monoclonal antibody (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puspitasari, Diah, Wanandi, Septelia I, Sadikin, Mohamad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587862/ https://www.ncbi.nlm.nih.gov/pubmed/35633567 http://dx.doi.org/10.31557/APJCP.2022.23.5.1803

Ejemplares similares

ARID1A Expression is Down-Regulated by Oxidative Stress in Endometriosis and Endometriosis-Associated Ovarian Cancer
por: Winarto, Hariyono, et al.
Publicado: (2017)

Inhibition of ALA dehydratase activity in heme biosynthesis reduces cytoglobin expression which is related to the proliferation and viability of keloid fibroblasts
por: Nauli, Raisa, et al.
Publicado: (2023)

Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells
por: Avvakumova, S., et al.
Publicado: (2019)

Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation
por: Syahrani, Resda A, et al.
Publicado: (2020)

Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells
por: Yin, Li, et al.
Publicado: (2020)

Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cells
por: Paramita, P, et al.
Publicado: (2018)

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
por: Tanei, Tomonori, et al.
Publicado: (2016)

Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells
por: Krisnamurti, Desak Gede Budi, et al.
Publicado: (2016)

Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines
por: Louisa, Melva, et al.
Publicado: (2016)

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
por: Juliá, Estefanía Paula, et al.
Publicado: (2020)

LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer
por: Obayemi, J. D., et al.
Publicado: (2020)

Profiling of Gene Expression Associated with Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2019)

Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines
por: Pruteanu, Lavinia-Lorena, et al.
Publicado: (2022)

Regulation and Signaling of TGF-β Autoinduction
por: Hariyanto, Narendra Ichiputra, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Extracellular Vesicles Increase Human MCF7 Breast Cancer Cell Proliferation associated with OCT4 Expression and ALDH Activity
por: Zakiyah, Nibras, et al.
Publicado: (2023)

In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2020)

Novel antibody–drug conjugates for triple negative breast cancer
por: Nagayama, Aiko, et al.
Publicado: (2020)

Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2021)

EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment
por: Zhang, Chaoyu, et al.
Publicado: (2022)

Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer
por: McKnight, Brooke N., et al.
Publicado: (2020)

Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
por: Arwanih, Elly Y, et al.
Publicado: (2022)

Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
por: Cabrera-Cabrera, Florencia, et al.
Publicado: (2023)

EFFECTS OF PUROMYCIN ON THE NUCLEOPROTEINS OF THE HELA CELL
por: Studzinski, G. P., et al.
Publicado: (1964)

Neuroglobin correlates with cryptochrome-1 in obstructive sleep apnea with primary aldosteronism
por: Tedjasukmana, Rimawati, et al.
Publicado: (2018)

The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
por: Adenina, Syarinta, et al.
Publicado: (2020)

Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium
por: Hardiany, Novi Silvia, et al.
Publicado: (2019)

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
por: Sihver, Wiebke, et al.
Publicado: (2014)

Moringa oleifera Leaves Extract Ameliorates Doxorubicin-Induced Cardiotoxicity via Its Mitochondrial Biogenesis Modulatory Activity in Rats
por: Patintingan, Cyntia Gracesella, et al.
Publicado: (2023)

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
por: Duncan, R., et al.
Publicado: (1987)

THE EFFECT OF PUROMYCIN ON INTRANUCLEAR STEPS IN RIBOSOME BIOSYNTHESIS
por: Soeiro, R., et al.
Publicado: (1968)

Structure of puromycin-sensitive aminopeptidase and polyglutamine binding
por: Madabushi, Sowmya, et al.
Publicado: (2023)

Asymmetric, amphiphilic RGD conjugated phthalocyanine for targeted photodynamic therapy of triple negative breast cancer
por: Li, Rui, et al.
Publicado: (2022)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
por: Si, Yingnan, et al.
Publicado: (2020)

Correlation Between Intensity of Vimentin Immuno-expression in Young Women with Triple Negative Breast Cancer and Its Cliniocopathological Parameters
por: Lumongga, Fitriani, et al.
Publicado: (2022)

Puromycin aminonucleoside modulates p130Cas of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2012)

The Role of Survivin in Podocyte Injury Induced by Puromycin Aminonucleoside
por: Li, Xuejuan, et al.
Publicado: (2014)

The role of PTEN in puromycin aminonucleoside-induced podocyte injury
por: Ren, Qi, et al.
Publicado: (2022)

In vitro Analysis of Stalled Ribosomes Using Puromycin Incorporation
por: Scarpitti, MaKenzie R., et al.
Publicado: (2023)

Suppression of Aβ toxicity by puromycin-sensitive aminopeptidase is independent of its proteolytic activity()
por: Kruppa, Antonina J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5j8mu34r5uob071ma6j57cmug7